Grace Science
Grace Science is a developer of small molecule inhibitors of NGLY1 to treat various forms of cancer.
Grace Science is a business in biotechnology, medical, pharmaceutical based in San Francisco Bay Area, West Coast, Western US, founded in 2017.
The company sits in the biotechnology, medical, pharmaceutical segment, where it competes on its core product or service.
Its base of operations is San Francisco Bay Area, West Coast, Western US.
It is recorded at the Seed stage.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $7M.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $7,000,000 |
Website: www.gracescience.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account